Comparing tirzepatide with B12 to other GLP-1 formulations Tirzepatide with B12 differs from semaglutide with B12 primarily through the dual GIP/GLP-1 mechanism
If there is clinical improvement and if a reticulocyte response is observed, the same amount may be given on alternate days for seven doses, then every 3 to 4 days for another 2 to 3 weeks
Conditions Commonly Caused by B12 Deficiencies B12 deficiencies are common and can cause a wide range of symptoms and health issues, including: Depression Fatigue, including chronic fatigue Poor concentration and memory Insomnia and other sleep disorders Headaches Heart disease Anemia Digestive disorders, including irritable bowel syndrome (IBS) Peripheral neuropathy Nearly anyone can suffer from a B12 deficiency
Higher B12 has been associated with reduced kidney function in population data, particularly among individuals with higher homocysteine concentrations
choose a different site with more subcutaneous tissue
Semaglutide should not be used after the expiration date printed on the packaging